Delivering mitochondrial health
Abliva will attend and present at the Mitochondria-Targeted Drug Development Summit in Boston, MA, USA. The event will be held on 22 - 24 February 2022. CEO Ellen Donnelly will […]
Abliva invites to a conference call and an online presentation on June 1, 2022, at 14:00 CEST. Abliva's CEO Ellen Donnelly, CMO Magnus Hansson and CFO Catharina Johansson will inform […]
Abliva will participate at the United Mitochondrial Disease Foundation's Mitochondrial Medicine Symposium in Phoenix, Arizona. Abliva's CMO, Magnus Hansson, will participate in a panel discussion on clinical trials together with […]
In light of our recent announcement and the continued developments in the company, we would like to invite shareholders and interested investors to an informal gathering to hear more about […]
In light of our recent announcement and the continued developments in the company, we would like to invite shareholders and interested investors to an informal gathering to hear more about […]
On June 29-30, Abliva will participate at Bioblast 2022: Inaugural Conference of Bioenergetics Communications in Innsbruck, Austria. Abliva's Communications Officer & Lab Manager, Eleonor Åsander Frostner, will present a summary […]
Abliva will be attending Aktiespararna's Digital Temadag - Life Science, on Aug 31, 2022. CEO Ellen Donnelly will present the company at 6:20 p.m. CEST. Follow link below for further […]
In September, Abliva will attend mitoNice, an international congress dedicated to Mitochondrial Medicine.
More info to come.
On September 26 (Monday), 2022, Abliva will attend Aktiespararna's Aktiedagen Lund, at Elite Hotel Ideon. CEO Ellen Donnelly will present the company at 4 p.m. CEST. See below for more […]
Abliva will attend the Nordic Life Science Days in Malmö, Sweden, on September 28-29, 2022. CEO Ellen Donnelly will be presenting the company at 11:00 CEST on Sep 29.
In October, Abliva will attend the Italian patient organization Mitocon's annual Mitochondrial Diseases Conference in Rome, Italy. On October 8, Abliva's Chief Medical Officer Magnus Hansson will give the talk: […]
